ArticleCancers2026
End-of-Induction Response and Tolerability of High-Risk Neuroblastoma Treated with Chemoimmunotherapy-Modified N7 Regimen with Dinutuximab Beta.
Evelyn R Lu, Calvin P L Hoo, Ho Ming Cheung, I W C Wong, K F Kevin Fung, Sylvia L Y Chang, Anselm C W Lee, Eric C H Fu, Dennis T L Ku, Jeffrey P W Yau and 4 more
Abstract read
In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Evelyn R LuDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.ORCID 0009-0009-8079-1845 Calvin P L HooDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
Ho Ming CheungNuclear Medicine Unit, Department of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital, Hong Kong, China.
I W C WongNuclear Medicine Unit, Department of Diagnostic and Interventional Radiology, Queen Elizabeth Hospital, Hong Kong, China.ORCID 0000-0002-0098-5570 K F Kevin FungDepartment of Radiology, Hong Kong Children's Hospital, Hong Kong, China.
Sylvia L Y ChangDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
Anselm C W LeeDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
Eric C H FuDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
Dennis T L KuDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.ORCID 0000-0003-0948-9132 Jeffrey P W YauDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.ORCID 0009-0001-5943-2735 Matthew M K ShingDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.ORCID 0000-0002-6641-9854 Christy Y K MakDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.ORCID 0000-0002-4261-7629 Anthony P Y LiuDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
Godfrey C F ChanDepartment of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Hong Kong, China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
anti-GD2dinutuximab betahigh-risk neuroblastomaimmunotherapyinduction chemotherapymodified N7
Identifiers
PMID41899628
PMCPMC13025792
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390